Cerebellar Atrophy with Phenytoin and Epilepsy
Cerebellar size measured by MRI was studied in a group of 36 adults (21 to 54 years, mean age 34 years) with intractable partial epilepsy treated with phenytoin longer than 4 years at the Epilepsy Center of the Long Island Jewish Medical Center, New Hyde Park, NY.
Saved in:
| Main Author: | J Gordon Millichap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1994-09-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relação dose-dependente do uso crônico de fenitoína e atrofia cerebelar em pacientes com epilepsia Dose-related cerebellar atrophy in patients with epilepsy using phenytoin
by: ANDRÉ DEL NEGRO, et al.
Published: (2000-06-01) -
Plasmapheresis as an Adjunctive Therapy in Phenytoin Poisoning
by: Purshotam Paudel, et al.
Published: (2024-11-01) -
IV Phenytoin and Soft Tissue Reaction in a Neonate
by: J Gordon Millichap
Published: (1994-12-01) -
Cognitive Effects of Carbamazepine and Phenytoin: Reanalysis
by: J Gordon Millichap
Published: (1991-02-01) -
Twinkle Mutations and Refractory Status Epilepticus
by: J Gordon Millichap
Published: (2009-07-01)